stockrowCharles River Laboratories International, Inc. (CRL) vs RadNet, Inc. (RDNT)
- Charles River Laboratories International, Inc. CRL 336.85 +7.61%
- RadNet, Inc. RDNT 75.66 −3.01%
Charles River Laboratories International, Inc. and RadNet, Inc. are both Diagnostics & Research companies. Charles River Laboratories International, Inc. is the larger, with a market value of $14.9B against $6.1B — 2.4× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; Charles River Laboratories International, Inc. trades at 322×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against −1.16%. Charles River Laboratories International, Inc. has the higher net margin (1.01% vs −0.93%) and the lower return on invested capital (1.81% vs 2.24%). Across the 20 metrics below, Charles River Laboratories International, Inc. leads on 10 and RadNet, Inc. on 10.
Valuation
Profitability
| Metric | CRL | RDNT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.33% | 11.53% | 48.32% |
| Operating margin | 4.00% | 3.12% | (5.68%) |
| Net margin | 1.01% | (0.93%) | (4.10%) |
| Free cash flow margin | 10.05% | 3.28% | 0.00% |
| Return on equity | 1.21% | (1.64%) | 0.00% |
| Return on assets | 0.54% | (0.55%) | (6.05%) |
| Return on invested capital | 1.81% | 2.24% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack